Common use of Trial Completion Clause in Contracts

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO INC Research of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO SPONSOR of all relevant Protocol-required data, Trial documents and Biological Samples; Samples (if applicable) and receipt of all payments due to either Party. c.party.\

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.(a) nedodržováním protokolu nebo písemných pokynů zadavatele stranou zbavenou odpovědnosti, (b) nedodržováním platných zákonů stranou zbavenou odpovědnosti nebo (c) nedbalostí nebo úmyslně protiprávním jednáním strany zbavené odpovědnosti. 17.2.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.party.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.škod vzniklých (a) nedodržováním protokolu nebo písemných pokynů zadavatele stranou zbavené odpovědnosti, (b) nedodržováním platných zákonů stranou zbavenou odpovědnosti nebo (c) nedbalostí nebo úmyslně protiprávním jednáním strany zbavené odpovědnosti. 17.2.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Party18.1 Podmínky ukončení. c.Tato smlouva bude ukončena v těchto případech podle toho, který z nich nastane dřív:

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.klinického hodnocení, Pro vyloučení pochybností, odškodnění podle tohoto článku 16 neomezuje žádné zákonné nároky jakékoli strany. 16.2.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents documents, Trial Data and Biological Samples; and receipt of all payments due to either Partyparty. c.18.1.3

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data18.1 Podmínky ukončení. Tato smlouva bude ukončena v těchto případech podle toho, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.který z nich nastane dřív: a.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-Protocol- required data, Trial documents and Biological Samples; and receipt of all payments due to either Party. c.b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samplesb. Dokončenie skúšania. Skúšanie sa, na účely tejto zmluvy, považuje za ukončené po dokončení všetkých činností požadovaných protokolom pre všetkých účastníkov skúšania, ktorí boli zaradení do skúšania; and receipt of all payments due to either Party. c.po odovzdaní všetkých príslušných údajov požadovaných protokolom, dokumentov

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-Protocol- required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all relevant Protocol-required data, Trial documents and Biological Samples; and receipt of all payments due to either Partyparty. c.b.

Trial Completion. For purposes of this Agreement, the Trial is considered complete after conclusion of all Protocol-required activities for all enrolled Trial Subjects; receipt by Sponsor or CRO of all Trial Data and other relevant Protocol-required data, Trial documents and Biological Samples, Trial Drug return, Trial Medication supplies return, electronically signed CRFs for all Trial Subjects, locked database, close-out and final monitoring visit; and receipt of all payments due to either Partyparty pursuant to the Agreement. c.b.